| abstract |
PRECISION OF DISCLOSURE: The invention relates to novel compositions. pharmaceutical containing in a pharmaceutical excipient-mentally acceptable, at least one of the mono, di and tri-esters of dihydroxy-1,8 phenyl-10 anthrone-9 or anthranol-9 responding to the general formula (I): (I) where p is 0 or 1, (a) when p = 0, t = 1 and R2 represents smells of a hydrogen atom or -COR3, (b) when p = 1, t = 0 and R1 and R2 independently of one another represent a hydrogen atom or -COR3, R3 representing an alkyl radical, linear or branched having from l to 17 carbon atoms, a cycloalkyl radical, or a phenyl radical optionally substituted by lower alkyl, lower alkoxy, a halogen atom, a nitro function, a -CF3 radical or a hydroxyl function, and mixtures of said esters. These compositions are useful as anti-proliferative agents, especially in the treatment of psoriasis and warts, or as anti-inflammatory agents in the treatment of rheumatism, dermatosis and eczema or as agents anti-acne. |